Erlotinib Induced Trichomegaly of the Eyelashes / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 37-40, 2013.
Artigo
em Inglês
| WPRIM
| ID: wpr-17410
ABSTRACT
Epithelial growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for non-small-cell lung cancer patients. Its untoward cutaneous effects are largely well known and developed in many patients treated with EGFR TKIs. However trichomegaly of eyelash is rarely reported. Although trichomegaly is not a drug-limiting side effect, it could be troublesome of continuing the treatment because of cosmetic issue or eyeball irritation by long eyelashes. Therefore clinicians are needed to pay attention to this uncommon effect. We herein describe erlotinib induced trichomegaly of eyelashes in a woman with adenocarcinoma of the lung.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Quinazolinas
/
Proteínas Tirosina Quinases
/
Adenocarcinoma
/
Cosméticos
/
Efeitos Fisiológicos de Drogas
/
Pestanas
/
Receptores ErbB
/
Cloridrato de Erlotinib
/
Pulmão
/
Neoplasias Pulmonares
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Tuberculosis and Respiratory Diseases
Ano de publicação:
2013
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS